Genetic Basis for Heterogeneity in Response of Plasma Lipids to Plant Sterols

Completed · Phase 4 · Has a placebo group

Conditions studied: Hyperlipidemia

In brief

The substantial range of individual responsiveness to plant sterols has important ramifications. Marked differences across individuals in particular aspects of the cholesterol metabolic pathway must alter the impact of plant sterol consumption. As such, a pronounced need exists to understand the genetic and metabolic factors that explain the substantial degree of heterogeneity in response of lipid concentrations to plant sterols across individuals. The primary focus of this trial is to delineate the impact of differing cholesterol synthesis levels on response of LDL-C and other plasma lipids to plant sterol consumption. Participants pre-identified as high or low endogenous cholesterol synthesizers, according to their screening level of lathosterol to cholesterol ratios, will be given PS or a placebo containing margarine to consume under supervision for 4 weeks in a crossover design. The trial will characterize the responsiveness of the participants' total, LDL, and HDL cholesterol, as well as triacylglycerol (TG) concentrations, to plant sterol consumption. This research will determine if cholesterol synthesis phenotype predicts the responsiveness of lipids to plant sterol consumption. Variations in candidate genes involved in cholesterol metabolism will also be investigated in order to find associations with both cholesterol metabolism phenotypes and responsiveness of lipids to plant sterols. The output of this research will be to advance the knowledge of which genetic factors influence the degree of cardiovascular benefit derived from plant sterols through lipid lowering.

Key facts

Study ID

NCT01131832

Run by

University of Manitoba

People needed

71

Starts

2010-09-01

Expected to finish

2012-02-01

Last updated by the study team

2017-05-09

Who can join

Age: 30 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• fasting serum LDL cholesterol >3.0 mmol/L
• high or low lathosterol to cholesterol ratio

You may not qualify if…

• smoking
• use of lipid lowering therapy
• documented cardiovascular/atherosclerotic disease
• inflammatory disease
• diabetes
• uncontrolled hypertension
• kidney disease
• liver disease
• other systemic diseases
• cancer
• chronic alcohol consumption (> 2 servings/day)

Where it is running

• USDA-ARS, Beltsville Human Nutrition Research Center — Beltsville, Maryland, United States
• Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba — Winnipeg, Manitoba, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.